• Merck & Co., Inc. (MRK) Stops Bone Drug Trial on Positive Results More...
• Gilead Sciences, Inc. (GILD)'s Truvada Pill Urged for AIDS Prevention After Promising Studies More...
• Orexigen Therapeutics, Inc. (OREX) Reports Strong Enrollment in Diet Pill Trial More...
• Genentech (RHHBY), deCODE genetics, Inc. (DCGN) Identify Protective Gene Against Alzheimer's, Cognitive Decline More...
• Cubist Pharmaceuticals, Inc. (CBST) Enrolls 1st Patient in Phase 3 Trial for Therapy to Treat Clostridium Difficile-Associated Diarrhea More...
• Pfizer Inc. (PFE) Recalls Robitussin Product Due to Label Errors More...
• Watson Laboratories, Inc. (WPI)'s Gets Approval for Generic Rheumatoid Arthritis Drug More...
• Arena Pharmaceuticals, Inc. (ARNA) Seeks Weight Control Drug Approval in Switzerland More...
• Do Shifty Eyes Really Mean You're Lying? University of Edinburgh,University of Hertfordshire Study More...
• Extra Pounds May Not Cut Lifespan, University of California, Davis (UCD) Study More...
• Moms' Caffeine Not Tied to Kids' Behavior Problems, Tilburg University Study More...
• Anxiety Linked to Shortened Telomeres, Accelerated Aging, Brigham and Women's Hospital Study More...
• Brain Abnormalities Seen in Children With Severe Form of Diabetes,Washington University School of Medicine Study More...
• Intellect Neurosciences, Inc. in Dispute With Pharmaceutical Licensee Over $2 Million Milestone Payment More...
• BioAlliance Pharma Extends and Strengthens the Protection of AMEPĂ‚® With the Grant of Two Patents in the US More...
• Actelion Ltd. (ALIOF.PK) to Cut 135 Jobs in R&D Revamp More...
• Rex Health Ventures Announces Inaugural Investment in N.C. Firm, Aerial BioPharma More...
• Verastem, Inc. (VSTM) Buys Pfizer Inc. (PFE) Cancer Drug Candidate in Deal Worth $126.5 Million More...
• Ipsen (IPN.PA) Scraps Planned Sale of French Site More...
• Watson Pharmaceuticals, Inc. (WPI) and Actavis Receive FTC Second Request More...
• AstraZeneca PLC (AZN) Acquires NeuroScience Assets From Link Medicine More...
• Alnylam Pharmaceuticals (ALNY), Ascletis, Inc. Create Strategic Collaboration to Develop ALN-VSP More...
• Verastem, Inc. (VSTM) Enters Research Collaboration With Eisai Company, Ltd. (ESALY.PK) for Small Molecule Wnt Inhibitors More...
• AstraZeneca PLC (AZN) and Leading Academic Scientists to Collaborate on Alzheimer's Disease Research More...
• Takeda Pharmaceutical Co. Ltd. (TKDG.DE) and Affymax, Inc. (AFFY) Announce Supply Agreement for OMONTYS® (peginesatide) Injection With Fresenius Medical Care North America More...
• R-Tech Ueno: Notification of Collaborative Study With Tohoku University on a New Drug Delivery System for Unoprostone More...
• Kala Pharmaceuticals Appoints Guillaume Pfefer, PhD as President and Chief Executive Officer More...
• New Management Team Appointed at Vitrolife, Thomas Axelsson New CEO More...
• Conatus Pharmaceuticals Inc. Appoints Mark F. Morris as Head of Biostatistics More...
• Bio-Rad Laboratories, Inc. (BIO) to Report Second-Quarter 2012 Financial Results Tuesday, August 7, 2012 More...
• Cubist Pharmaceuticals, Inc. (CBST) to Announce Second Quarter 2012 Financial Results on Thursday, July 19th, 2012 More...
• Orexo AB: Interim Report, January-June 2012 More...
• Raptor Pharmaceutical Inc. (RPTP) Announces Third Quarter Fiscal 2012 Financial Results More...
• Safeguard Scientifics (SFE) to Release Second Quarter 2012 Financial Results on Thursday, July 26 More...
• Johnson & Johnson (JNJ) Agrees to Beef Up Internal Oversight More...
• Bayer AG (BAY.F) to Pay $15 Million to Settle Aspirin Marketing Suit More...
• Gilead Sciences, Inc. (GILD)'s Truvada Pill Urged for AIDS Prevention After Promising Studies More...
• Orexigen Therapeutics, Inc. (OREX) Reports Strong Enrollment in Diet Pill Trial More...
• Genentech (RHHBY), deCODE genetics, Inc. (DCGN) Identify Protective Gene Against Alzheimer's, Cognitive Decline More...
• Cubist Pharmaceuticals, Inc. (CBST) Enrolls 1st Patient in Phase 3 Trial for Therapy to Treat Clostridium Difficile-Associated Diarrhea More...
• Pfizer Inc. (PFE) Recalls Robitussin Product Due to Label Errors More...
• Watson Laboratories, Inc. (WPI)'s Gets Approval for Generic Rheumatoid Arthritis Drug More...
• Arena Pharmaceuticals, Inc. (ARNA) Seeks Weight Control Drug Approval in Switzerland More...
• Do Shifty Eyes Really Mean You're Lying? University of Edinburgh,University of Hertfordshire Study More...
• Extra Pounds May Not Cut Lifespan, University of California, Davis (UCD) Study More...
• Moms' Caffeine Not Tied to Kids' Behavior Problems, Tilburg University Study More...
• Anxiety Linked to Shortened Telomeres, Accelerated Aging, Brigham and Women's Hospital Study More...
• Brain Abnormalities Seen in Children With Severe Form of Diabetes,Washington University School of Medicine Study More...
• Intellect Neurosciences, Inc. in Dispute With Pharmaceutical Licensee Over $2 Million Milestone Payment More...
• BioAlliance Pharma Extends and Strengthens the Protection of AMEPĂ‚® With the Grant of Two Patents in the US More...
• Actelion Ltd. (ALIOF.PK) to Cut 135 Jobs in R&D Revamp More...
• Rex Health Ventures Announces Inaugural Investment in N.C. Firm, Aerial BioPharma More...
• Verastem, Inc. (VSTM) Buys Pfizer Inc. (PFE) Cancer Drug Candidate in Deal Worth $126.5 Million More...
• Ipsen (IPN.PA) Scraps Planned Sale of French Site More...
• Watson Pharmaceuticals, Inc. (WPI) and Actavis Receive FTC Second Request More...
• AstraZeneca PLC (AZN) Acquires NeuroScience Assets From Link Medicine More...
• Alnylam Pharmaceuticals (ALNY), Ascletis, Inc. Create Strategic Collaboration to Develop ALN-VSP More...
• Verastem, Inc. (VSTM) Enters Research Collaboration With Eisai Company, Ltd. (ESALY.PK) for Small Molecule Wnt Inhibitors More...
• AstraZeneca PLC (AZN) and Leading Academic Scientists to Collaborate on Alzheimer's Disease Research More...
• Takeda Pharmaceutical Co. Ltd. (TKDG.DE) and Affymax, Inc. (AFFY) Announce Supply Agreement for OMONTYS® (peginesatide) Injection With Fresenius Medical Care North America More...
• R-Tech Ueno: Notification of Collaborative Study With Tohoku University on a New Drug Delivery System for Unoprostone More...
• Kala Pharmaceuticals Appoints Guillaume Pfefer, PhD as President and Chief Executive Officer More...
• New Management Team Appointed at Vitrolife, Thomas Axelsson New CEO More...
• Conatus Pharmaceuticals Inc. Appoints Mark F. Morris as Head of Biostatistics More...
• Bio-Rad Laboratories, Inc. (BIO) to Report Second-Quarter 2012 Financial Results Tuesday, August 7, 2012 More...
• Cubist Pharmaceuticals, Inc. (CBST) to Announce Second Quarter 2012 Financial Results on Thursday, July 19th, 2012 More...
• Orexo AB: Interim Report, January-June 2012 More...
• Raptor Pharmaceutical Inc. (RPTP) Announces Third Quarter Fiscal 2012 Financial Results More...
• Safeguard Scientifics (SFE) to Release Second Quarter 2012 Financial Results on Thursday, July 26 More...
• Johnson & Johnson (JNJ) Agrees to Beef Up Internal Oversight More...
• Bayer AG (BAY.F) to Pay $15 Million to Settle Aspirin Marketing Suit More...
A free new app called UMSkinCheck, designed for iPhone and iPad, will screen skin cancers by reminding users to compare unusual growths on their skin with actual photos provided by the app.
A collaboration of the University of Michigan Medical School technology and clinical expertise, the app guides users through a series of 23 photos, covering the body from head to toe.
Photos are stored within the app and serve as a baseline for future comparisons. The app will create a reminder to repeat a skin self-exam on a regular basis.
If a mole appears to be changing or growing, the photos can then be shared with a dermatologist to help determine whether a biopsy is necessary, according to a Michigan statement.
"We recommend skin self-exams for everyone in order to detect skin cancer at the earliest stages, when treatment is less invasive and more successful," said Michael Sabel, associate professor of surgery at the Michigan Medical School, who led the project to develop the app.
"If you have fair skin or burn easily, have had sunburns in the past or used tanning beds, or have a family history of melanoma, you are considered high-risk, and so it's even more important," Sabel added.
"Whole body photography is a well-established resource for following patients at risk for melanoma, (the most dangerous form of skin cancer)," said Sabel.
"However, it requires a professional photographer, is not always covered by insurance, and can be an inconvenience. Now that many people have digital cameras on their phones, it's more feasible to do this at home," added Sabel.
More than two million Americans are diagnosed with skin cancer each year, and some 50,000 will be diagnosed with melanoma. Regular skin checks can help people discover melanoma in its earliest stages.
A collaboration of the University of Michigan Medical School technology and clinical expertise, the app guides users through a series of 23 photos, covering the body from head to toe.
Photos are stored within the app and serve as a baseline for future comparisons. The app will create a reminder to repeat a skin self-exam on a regular basis.
If a mole appears to be changing or growing, the photos can then be shared with a dermatologist to help determine whether a biopsy is necessary, according to a Michigan statement.
"We recommend skin self-exams for everyone in order to detect skin cancer at the earliest stages, when treatment is less invasive and more successful," said Michael Sabel, associate professor of surgery at the Michigan Medical School, who led the project to develop the app.
"If you have fair skin or burn easily, have had sunburns in the past or used tanning beds, or have a family history of melanoma, you are considered high-risk, and so it's even more important," Sabel added.
"Whole body photography is a well-established resource for following patients at risk for melanoma, (the most dangerous form of skin cancer)," said Sabel.
"However, it requires a professional photographer, is not always covered by insurance, and can be an inconvenience. Now that many people have digital cameras on their phones, it's more feasible to do this at home," added Sabel.
More than two million Americans are diagnosed with skin cancer each year, and some 50,000 will be diagnosed with melanoma. Regular skin checks can help people discover melanoma in its earliest stages.
Becoming ,’ Crorepati’ is a dream which every Indian has. But the critical question is how to do that. While there are many ways to do become a crorepati, the one which strikes the mind is to participate in the popular television channel,’ Kaun Banega Crorepati’ and win a crore in the game show. But there comes the catch .It is not only difficult to get selected for the show, it is even more daunting task to win a crore in the program. But hang on! You need not get tensed! There is an easy way out and it comes from a common sense approach to investment. An investor you need to do two things to achieve the target. One is to start early and second is to invest with a long time horizon.
If you are 20 year old, all you need is to put Rs.28.50 in your piggy bank daily, withdraw it after a month and invest the same in a mutual fund. There is no need even to invest money daily. This can be your way to be a crorepati. While there is no element of guaranteed return here, power of compounding can work in favour of investor and help him achieve his target.
Let us understand it with an example and a set of assumptions. Assumptions are as follows:
Mr. X is 20 years old
He accumulates Rs. 28.50 every day for a month for 40 years in a piggy bank. After the end of month he withdraws money from piggy bank and invests it through SIP in a well diversified mutual fund
Mutual fund gives a return of 12% p.a., compounded monthly
Options are available to invest saved amount or else he can change the amount of investment to meet requirements of SIP amount.If Mr. X continues this process for 40 years, he will become a crorepati if all the assumptions mentioned hold good. Rs. 28.5 invested daily for a period of 40 years grows into a crore because of magic of power of compounding. This opportunity is available to even older people. However, they have to forgo some other consumption though in small quantity only. As a 30 years old person, you need to save Rs. 95 daily. As the age progresses, the savings required increases naturally. The chart below shows that:
Age
|
Time Frame
|
Daily Savings(In Rupees)
|
Expected Rate of Return
|
20
|
40 Years
|
28.5
|
12% p.a. (compounded)
|
30
|
30 Years
|
95
|
12% p.a. (compounded)
|
40
|
20 Years
|
340
|
12% p.a. (compounded)
|
So, what do you need to achieve the target of Rs. 1 crore as a twenty year old? No gigantic effort. Just skip a cup of tea and two cigarettes daily. What if, you are already a non-smoker and even don’t drink it. Find out an easy way of thriftiness, without changing your life style substantially. Thriftiness needs to be little more for a 30 year old person and much more for a 40 year old person. So why not start early as well.
( Moneycontrol, By Vivek Sharma, Financial Planner and Trainer )
The new additions to Facebook events are the Events calendar and a List view that highlight upcoming events so that users can plan well in advance for them.
A note by Facebook engineer Bob Baldwin on the Facebook engineering page said, "Today we announce a new list and calendar view that makes it easier to scan upcoming birthdays, invites and suggested events. Scroll through these events and respond to invites without leaving the page. Suggested events are recommended to you based on your friends, Pages you like, places you've checked in at and the apps you use on Facebook."
This Facebook Events redesign is the result of a Facebook hackathon, where Facebook engineers get together to hack on new ideas and try to build a prototype overnight. The Events hackathon project had started about a year ago.
A multibillion dollar trading loss at JP Morgan was reminded of a nightmare occurred when Lehman Brothers was collapsed in 2008. Trading bets went wrong and open position at trading house of JP Morgan predicting a loss of more than $9 billion dollars. It has put the image of JP Morgan as a one of the safe trading and investment bank of United States in question. Now the controversial report that shows that JP Morgan is No 1 stock picker as Investors rate brokers according to a bloomberg report.
That means that $9 billion trading was just a misfortune of J P Morgan and the latest report might shred the earlier tarnished image of J P Morgan
That means that $9 billion trading was just a misfortune of J P Morgan and the latest report might shred the earlier tarnished image of J P Morgan
Veteran Actor Dara Singh died at the age of 84 in Mumbai on Thursday. His doctor RK Aggarwal said, "He died due to cardiac respiratory arrest at around 7:30 am." Dara Singh will be cremated at 2 pm.
The 84-year-old had suffered severe brain damage following a cardiac arrest last week. He was shifted home from hospital on Wednesday night as his family wanted his final moments to be spent at home.
The grim news shook the film industry as well as the political fraternity. Actor Amitabh Bachchan tweeted, "Dara Singh ji passed away this morning. A great Indian and one of the finest humans..An entire era of his celebrated presence gone!"
Actor Shah Rukh Khan also tweeted, "Wrestlers r made of sweat,determination & a hard to find alloy called guts...most apt for Dara Singhji our very own Superman.Will miss u sir." (sic)
BJP leader Sushma Swaraj tweeted, "He distinguished himself not only as a sportsperson but also as an actor and a Member of Parliament."
The 84-year-actor was admitted to Kokilaben Hospital in an emergency condition on July 7. He had suffered a cardiac arrest and since then he has been in the ICU.
The Commonwealth wrestling champion entered film industry in the fifties and is known for his roles in 'King Kong' and 'Faulad'. He was last seen in Imtiaz Ali's 'Jab We Met' (2007) playing Kareena Kapoor's grandfather.
The veteran actor had played the character of Hanuman in Ramanand Sagar's epic television series 'Ramayan'.
The 84-year-old had suffered severe brain damage following a cardiac arrest last week. He was shifted home from hospital on Wednesday night as his family wanted his final moments to be spent at home.
The grim news shook the film industry as well as the political fraternity. Actor Amitabh Bachchan tweeted, "Dara Singh ji passed away this morning. A great Indian and one of the finest humans..An entire era of his celebrated presence gone!"
Actor Shah Rukh Khan also tweeted, "Wrestlers r made of sweat,determination & a hard to find alloy called guts...most apt for Dara Singhji our very own Superman.Will miss u sir." (sic)
BJP leader Sushma Swaraj tweeted, "He distinguished himself not only as a sportsperson but also as an actor and a Member of Parliament."
The 84-year-actor was admitted to Kokilaben Hospital in an emergency condition on July 7. He had suffered a cardiac arrest and since then he has been in the ICU.
The Commonwealth wrestling champion entered film industry in the fifties and is known for his roles in 'King Kong' and 'Faulad'. He was last seen in Imtiaz Ali's 'Jab We Met' (2007) playing Kareena Kapoor's grandfather.
The veteran actor had played the character of Hanuman in Ramanand Sagar's epic television series 'Ramayan'.
A California yoga instructor has been fired for her disapproving stink-eye glare at a Facebook employee using a cellphone in class.
Alice Van Ness, who was hired to teach hour-long yoga sessions at Facebook's Menlo Park campus, said that she would tell students before class to turn off their cellphones.
But a female employee pulled out her cellphone in the middle of a Monday session and began texting.
The San Jose Mercury News said Van Ness didn't say anything, but she gave the student what she calls a look of disapproval.
The student later complained and Van Ness was fired by Plus One Health Management.
The termination letter said Van Ness "made a spectacle" of the student.
Alice Van Ness, who was hired to teach hour-long yoga sessions at Facebook's Menlo Park campus, said that she would tell students before class to turn off their cellphones.
But a female employee pulled out her cellphone in the middle of a Monday session and began texting.
The San Jose Mercury News said Van Ness didn't say anything, but she gave the student what she calls a look of disapproval.
The student later complained and Van Ness was fired by Plus One Health Management.
The termination letter said Van Ness "made a spectacle" of the student.
Top Stories
Amid new pressures, China prepares for immediate stimulus
Chinese Premier Wen Jiabao is putting renewed emphasis on investment to sustain the country's growth amid worrying signs for the second quarter and in the jobs market. But a good deal of the effort apparently will be directed toward big state-owned companies. "Public investment will likely go up in coming months," said Zhang Zhiwei, chief China economist at Nomura Holdings, noting that this is probably "the only effective way to push up growth in the short term."
Rise in wholesale inventories reflects cooling U.S. economy
Even though oil inventories fell sharply, overall U.S. wholesale inventories were up a bit in May, echoing other indications of a cooling economy. As if to confirm that diagnosis, shipments for the U.S. box-making industry fell 0.6% in May on an average-week basis, the second consecutive month of decline.
U.S. trade deficit shrinks as exports to China, Europe grow
Stronger exports to China and Europe and lower oil prices helped narrow the U.S. trade gap by 3.8% in May. Exports for the month were up 0.2% but, given the unresolved crisis in the eurozone, this is unlikely to be sustained. "Exports are holding up, but as we go forward we are going to see pretty weak numbers given the slowdown abroad," said Jay Bryson of Wells Fargo Securities.
Fitch retains negative outlook for AAA-rated U.S.
The U.S. maintains its AAA rating by Fitch Ratings, but the outlook remains negative as well, with the agency citing Washington's deadlock over deficit reduction. "The uncertainty over tax and spending policies associated with the so-called 'fiscal cliff' weighs on the near-term economic outlook," Fitch said.
Spain announces 65 billion-euro austerity package
Facing pressure from its eurozone partners and an increasingly restive public, Spain unveiled 65 billion euros' worth of tax increases and budget cuts. As striking miners marched in Madrid, Prime Minister Mariano Rajoy announced the austerity package, telling parliament that "these measures are not pleasant, but they are necessary."
Diamond offers to return for more testimony on Libor, Barclays
Former Barclays CEO Bob Diamond would like to testify again before Parliament in the U.K. to deny claims that he was misleading in previous testimony over Libor manipulation. More hearings on the matter are set for next week, with Bank of England Governor Mervyn King and Deputy Governor Paul Tucker among those on the schedule.
Market Activities
INTERNATIONAL MARKETS OVERVIEW
The focus in the U.S. stock market Wednesday was the minutes from the Federal Reserve Board's June meeting, in which it was indicated that more stimulus might be warranted, but only if the economy turns for the worse. The news left the key S&P 500 unchanged, but the Dow Jones industrials and Nasdaq both declined. Stocks in Europe were mixed for the day. Here is a continuously updated listed of global stock indexes.
Economic Trends & Outlook
China's purchases bolster gold reserves
In a sign that mainland China is beefing up its gold reserves, the government has bought 315 tons of gold from Hong Kong this year through May. According to a Bloomberg report, China's gold imports from Hong Kong rose more than sixfold in the first quarter alone as gold again found popular demand as an investment tool.
Australian rate cuts begin to buoy consumer outlook
Australian consumer sentiment remains narrowly in negative territory, according to a July reading, though recent interest rate cuts have helped. "Finally, we have some evidence that the Reserve Bank's policy of cutting the official cash rate by 125 basis points between November last year and June this year is starting to gain more positive traction with households," said Westpac chief economist Bill Evans. "However, this result is far from convincing and should not be interpreted that we can expect confidence to steadily return to more normal levels over the months ahead."
China's share of Taiwan exports declines, easing reliance fears
Fears that Taiwan may be growing too reliant on mainland China and Hong Kong for exports were eased somewhat by first-half figures that show 38.1% of Taiwan exports going across the strait, the lowest share in several years. Officials traced the lower figure to the impact of the European debt crisis on China's economy.
Tax boost is targeted as Japan's Ozawa launches new party
Vowing to thwart plans to double Japan's consumption tax, Ichiro Ozawa introduced his new party, the latest threat to Yoshihiko Noda as prime minister. "Our first goal is to overturn the tax hike bill," Ozawa said as he unveiled the People's Livelihoods First party, which launches as the third-largest in parliament's lower house.
Analysts tone down government projections for Philippine economy
Countering Philippine government projections of steadily rising growth rates over the next three years, possibly hitting 8% by 2015, analysts say the prospects are good but not that bright. A more realistic outlook is 6% annual growth or slightly higher for the next five years, said DBS Bank economist Eugene Leow. Others noted that growth rates would depend on reducing domestic corruption and improving investment rules as well as the international economic climate, which remains uncertain.
Foreign hedge funds have been cleared by Beijing to do business with wealthy Chinese for investments abroad, people in the industry say.
Foreign direct investment in China eases
Foreign direct investment in China was down 1.9% in the first five months of the year from the year-earlier period, according to a report by the U.N. Conference on Trade and Development. The report noted difficulties in finding loose investment funds in a global economic climate constrained by economic uncertainty.
Traders seek safety in rapidly growing South Korean bond market
Daily volume in South Korea's bond market has nearly doubled since the beginning of the year as sovereign bonds win the attention of traders amid a flight to safety in uncertain times. The gains come at the expense of stocks, with capitalization of the Kospi market declining by 100 trillion won over the past two months.
Standard Chartered advises less Taiwan equity exposure
Investors should reduce their exposure to Taiwanese equities while the world works through its current economic difficulties, advises Standard Chartered Bank. "We see a muddle-through scenario as likely to continue in the coming months and possibly years. ... Data around the world has been weaker than expected," Steve Brice, chief investment strategist at Standard Chartered, said in Taipei.
Mumbai exchange rises
Mumbai's MCX Stock Exchange has been cleared by regulators to trade equity and stock derivatives, making it India's third full stock exchange. The Mumbai exchange, also known as MCX-SX, currently trades only in currency futures.
People & Personalities
AlpInvest to focus on Asia from Hong Kong base
AlpInvest Partners of the Netherlands plans to allocate 10% to 20% of its 1 billion euros in annual second private-equity investments to Asia and other emerging markets through its new secondary-investments office in Hong Kong. Neal Costello from AlpInvest's New York office will run the Hong Kong operation, which is soon to be joined by Nicole Ying Su from the secondaries team in Amsterdam.
Banking-job cuts appear likely across Asia
Persistent global economic woes probably mean further reductions in the ranks of bankers across Asia, joining recent job cuts by Credit Suisse, Morgan Stanley, Deutsche Bank and Goldman Sachs.
Amid new pressures, China prepares for immediate stimulus
Chinese Premier Wen Jiabao is putting renewed emphasis on investment to sustain the country's growth amid worrying signs for the second quarter and in the jobs market. But a good deal of the effort apparently will be directed toward big state-owned companies. "Public investment will likely go up in coming months," said Zhang Zhiwei, chief China economist at Nomura Holdings, noting that this is probably "the only effective way to push up growth in the short term."
Rise in wholesale inventories reflects cooling U.S. economy
Even though oil inventories fell sharply, overall U.S. wholesale inventories were up a bit in May, echoing other indications of a cooling economy. As if to confirm that diagnosis, shipments for the U.S. box-making industry fell 0.6% in May on an average-week basis, the second consecutive month of decline.
U.S. trade deficit shrinks as exports to China, Europe grow
Stronger exports to China and Europe and lower oil prices helped narrow the U.S. trade gap by 3.8% in May. Exports for the month were up 0.2% but, given the unresolved crisis in the eurozone, this is unlikely to be sustained. "Exports are holding up, but as we go forward we are going to see pretty weak numbers given the slowdown abroad," said Jay Bryson of Wells Fargo Securities.
Fitch retains negative outlook for AAA-rated U.S.
The U.S. maintains its AAA rating by Fitch Ratings, but the outlook remains negative as well, with the agency citing Washington's deadlock over deficit reduction. "The uncertainty over tax and spending policies associated with the so-called 'fiscal cliff' weighs on the near-term economic outlook," Fitch said.
Spain announces 65 billion-euro austerity package
Facing pressure from its eurozone partners and an increasingly restive public, Spain unveiled 65 billion euros' worth of tax increases and budget cuts. As striking miners marched in Madrid, Prime Minister Mariano Rajoy announced the austerity package, telling parliament that "these measures are not pleasant, but they are necessary."
Diamond offers to return for more testimony on Libor, Barclays
Former Barclays CEO Bob Diamond would like to testify again before Parliament in the U.K. to deny claims that he was misleading in previous testimony over Libor manipulation. More hearings on the matter are set for next week, with Bank of England Governor Mervyn King and Deputy Governor Paul Tucker among those on the schedule.
Market Activities
INTERNATIONAL MARKETS OVERVIEW
The focus in the U.S. stock market Wednesday was the minutes from the Federal Reserve Board's June meeting, in which it was indicated that more stimulus might be warranted, but only if the economy turns for the worse. The news left the key S&P 500 unchanged, but the Dow Jones industrials and Nasdaq both declined. Stocks in Europe were mixed for the day. Here is a continuously updated listed of global stock indexes.
Economic Trends & Outlook
China's purchases bolster gold reserves
In a sign that mainland China is beefing up its gold reserves, the government has bought 315 tons of gold from Hong Kong this year through May. According to a Bloomberg report, China's gold imports from Hong Kong rose more than sixfold in the first quarter alone as gold again found popular demand as an investment tool.
Australian rate cuts begin to buoy consumer outlook
Australian consumer sentiment remains narrowly in negative territory, according to a July reading, though recent interest rate cuts have helped. "Finally, we have some evidence that the Reserve Bank's policy of cutting the official cash rate by 125 basis points between November last year and June this year is starting to gain more positive traction with households," said Westpac chief economist Bill Evans. "However, this result is far from convincing and should not be interpreted that we can expect confidence to steadily return to more normal levels over the months ahead."
China's share of Taiwan exports declines, easing reliance fears
Fears that Taiwan may be growing too reliant on mainland China and Hong Kong for exports were eased somewhat by first-half figures that show 38.1% of Taiwan exports going across the strait, the lowest share in several years. Officials traced the lower figure to the impact of the European debt crisis on China's economy.
Tax boost is targeted as Japan's Ozawa launches new party
Vowing to thwart plans to double Japan's consumption tax, Ichiro Ozawa introduced his new party, the latest threat to Yoshihiko Noda as prime minister. "Our first goal is to overturn the tax hike bill," Ozawa said as he unveiled the People's Livelihoods First party, which launches as the third-largest in parliament's lower house.
Analysts tone down government projections for Philippine economy
Countering Philippine government projections of steadily rising growth rates over the next three years, possibly hitting 8% by 2015, analysts say the prospects are good but not that bright. A more realistic outlook is 6% annual growth or slightly higher for the next five years, said DBS Bank economist Eugene Leow. Others noted that growth rates would depend on reducing domestic corruption and improving investment rules as well as the international economic climate, which remains uncertain.
Capital Markets & Financial Products
Foreign hedge funds get clearance to find clients in China
Foreign hedge funds get clearance to find clients in China
Foreign hedge funds have been cleared by Beijing to do business with wealthy Chinese for investments abroad, people in the industry say.
Foreign direct investment in China eases
Foreign direct investment in China was down 1.9% in the first five months of the year from the year-earlier period, according to a report by the U.N. Conference on Trade and Development. The report noted difficulties in finding loose investment funds in a global economic climate constrained by economic uncertainty.
Traders seek safety in rapidly growing South Korean bond market
Daily volume in South Korea's bond market has nearly doubled since the beginning of the year as sovereign bonds win the attention of traders amid a flight to safety in uncertain times. The gains come at the expense of stocks, with capitalization of the Kospi market declining by 100 trillion won over the past two months.
Standard Chartered advises less Taiwan equity exposure
Investors should reduce their exposure to Taiwanese equities while the world works through its current economic difficulties, advises Standard Chartered Bank. "We see a muddle-through scenario as likely to continue in the coming months and possibly years. ... Data around the world has been weaker than expected," Steve Brice, chief investment strategist at Standard Chartered, said in Taipei.
Mumbai exchange rises
Mumbai's MCX Stock Exchange has been cleared by regulators to trade equity and stock derivatives, making it India's third full stock exchange. The Mumbai exchange, also known as MCX-SX, currently trades only in currency futures.
People & Personalities
AlpInvest to focus on Asia from Hong Kong base
AlpInvest Partners of the Netherlands plans to allocate 10% to 20% of its 1 billion euros in annual second private-equity investments to Asia and other emerging markets through its new secondary-investments office in Hong Kong. Neal Costello from AlpInvest's New York office will run the Hong Kong operation, which is soon to be joined by Nicole Ying Su from the secondaries team in Amsterdam.
Banking-job cuts appear likely across Asia
Persistent global economic woes probably mean further reductions in the ranks of bankers across Asia, joining recent job cuts by Credit Suisse, Morgan Stanley, Deutsche Bank and Goldman Sachs.
• Forest Laboratories, Inc. (FRX) Hires Search Firm to Hunt for New CEO More...
• Gen9 Announces Appointment of Kevin Munnelly as President and CEO More...
• Brian Klein to Join Stifel Nicolaus' Healthcare Equity Research Team More...
• Lance Alstodt Joins Leerink Swann and Company More...
• Edmond de Rothschild Raises $152 Million for Its Fourth Life Sciences Fund More...
• Walvax Biotech Gains Majority Control of Fengmao Biotech More...
• Actinium Pharmaceuticals, Inc. Licenses Monoclonal Antibody From Fred Hutchinson Cancer Research Center More...
• Merck & Co., Inc. (MRK) Announces Collaboration to Improve Maternal Health through Expanded Access to Family Planning More...
• Research Corporation Technologies Partners with Isogenica Limited for Large Scale Screening of a New Antibody-Derived Scaffold Platform More...
• Baylor College of Medicine and Gradalis Inc. Enter Collaboration Agreement to Utilize Gradalis' Bifunctional shRNA Platform in Translational Medicine Research More...
• Echo Therapeutics Expands License Agreement with Ferndale Pharma More...
• Alexion Pharmaceuticals Inc. (ALXN) to Report Second Quarter 2012 Results on Wednesday, July 25, 2012 More...
• AmerisourceBergen Corporation (ABC) Announces Date and Time for Fiscal Third Quarter Earnings Release More...
• BioMarin Pharmaceutical Inc. (BMRN) to Host Second Quarter 2012 Financial Results Conference Call and Webcast on Wednesday, August 1 at 5:00 p.m. ET More...
• BioClinica, Inc. to Release Second Quarter 2012 Financial Results on August 8, 2012 More...
• Ironwood Pharmaceuticals to Host Second Quarter 2012 Investor Update Call More...
• AstraZeneca PLC (AZN) Loses Fight Over Generic Seroquel More...
• Teva Pharmaceutical Industries Limited (TEVA) Announces Favorable United Kingdom Court Ruling in COPAXONE® Patent Litigation Proceeding More...
• FDA Suspends Ipsen (IPN.PA)'s Ph3 Hemophilia Drug Study More...
• Eli Lilly and Company (LLY) Schizophrenia Drug Fails Late-stage Trial More...
• Blow for BioInvent (BOVNF) as Vascular Treatment Fails More...
• Eisai Inc. (ESALF.PK)'s Halavan Misses Endpoints in Phase III Trial More...
• GlaxoSmithKline (GSK), Shionogi & Co., Ltd. Say HIV Drug Beats Gilead Sciences, Inc. (GILD) Atripla in Test More...
• Links Medical Receives Both FDA & EU Market Clearance for Advance Wound Care Products With Medical-Grade Manuka Honey More...
• Hemispherx Biopharma (HEB) and the FDA Reach Agreement on Filing Requirements for the Company's Complete Response in Support of Ampligen® New Drug Application for Chronic Fatigue Syndrome Treatment More...
• 3 Drinks a Week Found to Cut Arthritis Risk by Half, Karolinska Institute Study More...
• U.S. Patients Get More Cancer Drugs Access, But Pay for Privilege, Tufts Center for the Study of Drug Development Study More...
• Food in Smaller Pieces May Help Control Weight, Arizona State University Study More...
• Quitting Smoking Packs on More Pounds Than Thought, University of Paris Study More...
• Early-Life Exposure to PCE, Chemical in Drinking Water, May Affect Vision,Boston University School of Public Health Study More...
• Oramed Pharmaceuticals Inc. (ORMP.OB) Granted 2nd Patent in New Zealand; 3rd Patent for Core Technology on Oral Delivery of Proteins More...
• NuPathe Inc. (PATH) Announces Allowance of Additional U.S. Patent Application for NP202 More...
• SCOLR Pharma, Inc. (DDD) Announces Issuance of European Patent for CDT® Ibuprofen More...
• Gen9 Announces Appointment of Kevin Munnelly as President and CEO More...
• Brian Klein to Join Stifel Nicolaus' Healthcare Equity Research Team More...
• Lance Alstodt Joins Leerink Swann and Company More...
• Edmond de Rothschild Raises $152 Million for Its Fourth Life Sciences Fund More...
• Walvax Biotech Gains Majority Control of Fengmao Biotech More...
• Actinium Pharmaceuticals, Inc. Licenses Monoclonal Antibody From Fred Hutchinson Cancer Research Center More...
• Merck & Co., Inc. (MRK) Announces Collaboration to Improve Maternal Health through Expanded Access to Family Planning More...
• Research Corporation Technologies Partners with Isogenica Limited for Large Scale Screening of a New Antibody-Derived Scaffold Platform More...
• Baylor College of Medicine and Gradalis Inc. Enter Collaboration Agreement to Utilize Gradalis' Bifunctional shRNA Platform in Translational Medicine Research More...
• Echo Therapeutics Expands License Agreement with Ferndale Pharma More...
• Alexion Pharmaceuticals Inc. (ALXN) to Report Second Quarter 2012 Results on Wednesday, July 25, 2012 More...
• AmerisourceBergen Corporation (ABC) Announces Date and Time for Fiscal Third Quarter Earnings Release More...
• BioMarin Pharmaceutical Inc. (BMRN) to Host Second Quarter 2012 Financial Results Conference Call and Webcast on Wednesday, August 1 at 5:00 p.m. ET More...
• BioClinica, Inc. to Release Second Quarter 2012 Financial Results on August 8, 2012 More...
• Ironwood Pharmaceuticals to Host Second Quarter 2012 Investor Update Call More...
• AstraZeneca PLC (AZN) Loses Fight Over Generic Seroquel More...
• Teva Pharmaceutical Industries Limited (TEVA) Announces Favorable United Kingdom Court Ruling in COPAXONE® Patent Litigation Proceeding More...
• FDA Suspends Ipsen (IPN.PA)'s Ph3 Hemophilia Drug Study More...
• Eli Lilly and Company (LLY) Schizophrenia Drug Fails Late-stage Trial More...
• Blow for BioInvent (BOVNF) as Vascular Treatment Fails More...
• Eisai Inc. (ESALF.PK)'s Halavan Misses Endpoints in Phase III Trial More...
• GlaxoSmithKline (GSK), Shionogi & Co., Ltd. Say HIV Drug Beats Gilead Sciences, Inc. (GILD) Atripla in Test More...
• Links Medical Receives Both FDA & EU Market Clearance for Advance Wound Care Products With Medical-Grade Manuka Honey More...
• Hemispherx Biopharma (HEB) and the FDA Reach Agreement on Filing Requirements for the Company's Complete Response in Support of Ampligen® New Drug Application for Chronic Fatigue Syndrome Treatment More...
• 3 Drinks a Week Found to Cut Arthritis Risk by Half, Karolinska Institute Study More...
• U.S. Patients Get More Cancer Drugs Access, But Pay for Privilege, Tufts Center for the Study of Drug Development Study More...
• Food in Smaller Pieces May Help Control Weight, Arizona State University Study More...
• Quitting Smoking Packs on More Pounds Than Thought, University of Paris Study More...
• Early-Life Exposure to PCE, Chemical in Drinking Water, May Affect Vision,Boston University School of Public Health Study More...
• Oramed Pharmaceuticals Inc. (ORMP.OB) Granted 2nd Patent in New Zealand; 3rd Patent for Core Technology on Oral Delivery of Proteins More...
• NuPathe Inc. (PATH) Announces Allowance of Additional U.S. Patent Application for NP202 More...
• SCOLR Pharma, Inc. (DDD) Announces Issuance of European Patent for CDT® Ibuprofen More...